S.D. Codified Laws § 36-11A-4.2
Current through the 2024 Legislative Session
No outsourcing facility engaged in compounding of nonpatient specific sterile and nonsterile drugs may become licensed by the board without first obtaining a registration and inspection by the United States Food and Drug Administration, and paying the license fee set by the board in rules promulgated pursuant to chapter 1-26. The fee may not exceed two hundred dollars.
SDCL 36-11A-4.2